<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01261078</url>
  </required_header>
  <id_info>
    <org_study_id>SMC-2010-12-05</org_study_id>
    <nct_id>NCT01261078</nct_id>
  </id_info>
  <brief_title>The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine</brief_title>
  <official_title>The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine for Spinal Anesthesia in Total Knee Replacement Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrathecal epinephrine has been known to increase the duration of spinal anesthesia, or
      increase the quality of anesthesia. However, there is still a controversy, and the mechanism
      of epinephrine is recently suggested as a modulator of pain information in the spinal cord.
      Therefore, the investigators try to investigate the dose sparing effect of intrathecal
      epinephrine for spinal anesthesia with bupivacaine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For patient undergoing total knee replacement arthroplasty, patients injected intrathecally
      with bupivacaine 8 mg were compared with those with bupivacaine 8 mg with 25 mcg of
      epinephrine, bupivacaine 8 mg with 50 mcg of epinephrine, and those with bupivacaine 8 mg
      with 100 mcg of epinephrine. The investigators compared the characteristics of spinal
      anesthesia including the quality and complication of spinal anesthesia. The researchers
      investigated whether intrathecal dose of epinephrine can reduce bupivacaine requirement and
      this effect is dependent on the dose of epinephrine.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the sensory level of spinal anesthesia, the quality of intraoperative analgesia</measure>
    <time_frame>every 15 minutes</time_frame>
    <description>at 2, 5, 10, 20, and 30 min after the spinal injection and every 15 minutes thereafter until complete regression of spinal anesthesia.</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Spinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>8 mg bupivacaine only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi 25</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 mg of bupivacaine mixed with 25 mcg of epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi 50</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 mg of bupivacaine mixed with 50 mcg of epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi 100</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 mg of bupivacaine mixed with 0.1 mg of epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi 200</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal bupivacaine 8 mg with 200 mcg of epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>intrathecal 8 mg of bupivacaine only</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Epinephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epinephrine 25</intervention_name>
    <description>intrathecal 8 mg of bupivacaine mixed with 25 mcg of epinephrine</description>
    <arm_group_label>Epi 25</arm_group_label>
    <other_name>Epinephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine 50</intervention_name>
    <description>intrathecal 8 mg of bupivacaine mixed with 50 mcg of epinephrine</description>
    <arm_group_label>Epi 50</arm_group_label>
    <other_name>Epinephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epinephrine 100</intervention_name>
    <description>intrathecal 8 mg of bupivacaine mixed with 0.1 mg of epinephrine</description>
    <arm_group_label>Epi 100</arm_group_label>
    <other_name>Epinephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epi 200</intervention_name>
    <description>intrathecal bupivacaine 8 mg with 200 mcg of epinephrine</description>
    <arm_group_label>Epi 200</arm_group_label>
    <other_name>epinephrine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient undergoing total knee replacement arthroplasty

        Exclusion Criteria:

          -  patient with cardiac or pulmonary disease (ASA class III or more)

          -  patient undergone previous spine surgery

          -  patient undergoing revised knee replacement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won Ho Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-740</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2010</study_first_submitted>
  <study_first_submitted_qc>December 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2010</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Won Ho Kim M.D. Faculty anesthesiologist</name_title>
    <organization>Seoul Meducal Center</organization>
  </responsible_party>
  <keyword>intrathecal epinephrine</keyword>
  <keyword>duration of anesthesia</keyword>
  <keyword>quality of anesthesia</keyword>
  <keyword>intrathecal fentanyl</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

